Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023 08:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Clinical Microbiology Global Market Report 2022: Integration of Automation in Laboratories Drives Growth
December 21, 2022 05:18 ET
|
Research and Markets
Dublin, Dec. 21, 2022 (GLOBE NEWSWIRE) -- The "Clinical Microbiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology
December 07, 2022 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company, providing mission critical automation...
Industrial Microbiology Global Market Report 2022: Continued Investments in Both Pharmaceutical and Food Industries Bode Well for Sector
November 25, 2022 07:28 ET
|
Research and Markets
Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "Industrial Microbiology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Worldwide Rapid Microbiology Tests Industry to 2030 - North America was the Largest Market in 2021
November 25, 2022 05:58 ET
|
Research and Markets
Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Rapid Microbiology Tests Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results
November 10, 2022 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2022 commercial revenue of $4.7 million Delivered year-over-year recurring revenue growth of 34% Reaffirms full year 2022 commercial revenue guidance of at least $17.0 million ...
Rapid Micro Biosystems to Announce Third Quarter 2022 Financial Results on November 10, 2022
November 02, 2022 08:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Global In Vitro Diagnostics Market Report 2022 to 2032: Featuring Roche Diagnostics, Siemens Healthineers, Danaher and Abbott Among Others
October 27, 2022 07:38 ET
|
Research and Markets
Dublin, Oct. 27, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics Market" report has been added to ResearchAndMarkets.com's offering.A recent market study on the market offers global industry...
Global Pharmaceutical Rapid Microbiology Testing Market Report 2022-2030: Low Cost and High Speed to Fuel Market Growth of Immunology Based Methods
October 26, 2022 07:53 ET
|
Research and Markets
Dublin, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Rapid Microbiology Testing Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
In Vitro Diagnostics Global Market Report 2022: Featuring Siemens, Sysmex, Bio-Rad, Abbott, Becton Dickinson & Others
October 12, 2022 06:28 ET
|
Research and Markets
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics Market, by Product Type, by Technology, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity...